Finorify

CVS

Cvs Health Corp

$87.60-0.38%

Price

CVS daily closing price
Market cap
$111.95 billion
P/E (TTM)
23.11
EV/EBITDA
12.50
52W range
$70.08 – $110.60
Div yield
3.04%
Volume
5.4M
Sector
Consumer Cyclical

Cvs Health Corp (CVS) last closed at $87.60, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for CVS, covered for search and blurred for visitors.

Performance

  • 1D-1.37%
  • 5D+3.39%
  • 1M+7.29%
  • 3M-12.57%
  • 6M+22.27%
  • 1Y+13.30%
  • 5Y+12.37%

Financials

CVS revenueQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Over the latest four reported periods ending June 30, 2026, Cvs Health Corp reported revenue of $415.09 billion.

The prior window totaled $386.64 billion, so the latest window is higher than that stretch.

Operating cash flow in the latest window was $14.78 billion.

Free cash flow in the latest window was $11.76 billion.

These amounts are taken from Cvs Health Corp's SEC filings and are a snapshot as of June 30, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE 3.7% (11 of 100). Leverage: D/E 0.75× (70 of 100). Cash generation: FCF margin 2.8% (6 of 100). Net margin: 2.8% (7 of 100). Liquidity: Current 0.87× (43 of 100).

Cash Flow

CVS free cash flowQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Margins

CVS operating margin

Valuation

P/E (TTM)
23.11
P/S (TTM)
0.27
EV/EBITDA
12.50

Insights

Finorify has not written notes for CVS in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open CVS in Finorify